Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Ahmedabad

    Tag: Ahmedabad

    You Searched For "Ahmedabad"
    Zydus Cadila gets USFDA nod for generic Misoprostol tablets to treat ulcers

    Zydus Cadila gets USFDA nod for generic Misoprostol tablets to treat ulcers

    Medical Dialogues Bureau5 July 2019 11:52 AM IST
    New Delhi: Drug firm Zydus Cadila Wednesday said it has received the final nod from the US health regulator to market its generic Misoprostol tablets...
    Zydus Cadila gets USFDA nod for Chlorthalidone tablets to treat high BP

    Zydus Cadila gets USFDA nod for Chlorthalidone tablets to treat high BP

    Farhat Nasim13 May 2019 10:31 AM IST
    Zydus Cadila said Chlorthalidone tablets will be manufactured at the group's formulations manufacturing facility at SEZ, Ahmedabad.New Delhi: Drug...
    Cadila Healthcare gets 14 USFDA observations for Moraiya plant

    Cadila Healthcare gets 14 USFDA observations for Moraiya plant

    Farhat Nasim4 May 2019 10:00 AM IST
    The US Food and Drug Administration (USFDA) inspected the plant from April 22, 2019 to May 3, 2019, Cadila Healthcare said in a regulatory filing.New...
    Zydus Cadila gets final USFDA nod to generic version of Diamox for injection

    Zydus Cadila gets final USFDA nod to generic version of Diamox for injection

    Farhat Nasim18 April 2019 10:00 AM IST
    Acetazolamide injection is a generic version of Diamox for injection.New Delhi: Drug firm Zydus Cadila Wednesday said it has received the final nod...
    Zydus Cadila gets tentative USFDA nod for Mirabegron ER tablets to treat overactive bladder

    Zydus Cadila gets tentative USFDA nod for Mirabegron ER tablets to treat overactive bladder

    Farhat Nasim2 April 2019 11:50 AM IST
    The company has received tentative approval from the United States Food and Drug Administration (USFDA) to market generic Mirabegron extended-release...
    Zydus Cadila gets USFDA nod for blood pressure treatment drug

    Zydus Cadila gets USFDA nod for blood pressure treatment drug

    Ruby Khatun Khatun30 Nov 2017 10:45 AM IST
    New Delhi: Cadila Healthcare said group firm Zydus Cadila has received final approval from the US health regulator to market Candesartan Cilexetil and...
    Shalby fixes price band between Rs 245-248 per share for IPO

    Shalby fixes price band between Rs 245-248 per share for IPO

    Ruby Khatun Khatun30 Nov 2017 10:30 AM IST
    Mumbai: Ahmedabad-based multi-specialty hospital chain Shalby said it has fixed the price band between Rs 245 to Rs 248 per equity share for its...
    Zydus gets USFDA nod for seizure, migraine drug

    Zydus gets USFDA nod for seizure, migraine drug

    Ruby Khatun Khatun28 Nov 2017 1:53 PM IST
    New Delhi: Drug firm Zydus Cadila said it has received final approval from the US health regulator to market Topiramate extended-release capsules,...
    Zydus Cadila gets USFDA nod to sell erectile dysfunction drug

    Zydus Cadila gets USFDA nod to sell erectile dysfunction drug

    Ruby Khatun Khatun24 Nov 2017 11:05 AM IST
    New Delhi: Drug firm Zydus Cadila said it has received approval from the US health regulator to market Tadalafil tablets, used for the treatment of...
    Zydus Cadila gets USFDA nod for swelling reducing drug

    Zydus Cadila gets USFDA nod for swelling reducing drug

    Ruby Khatun Khatun20 Nov 2017 10:02 AM IST
    New Delhi: Zydus Cadila has received final approval from the US health regulator to market Ethacrynate sodium for injection, used to reduce swelling...
    Zydus gets USFDA nod for overactive bladder drug

    Zydus gets USFDA nod for overactive bladder drug

    Ruby Khatun Khatun6 Oct 2017 9:49 AM IST
    New Delhi: Drug firm Zydus Cadila said it has received final approval from the US health regulator to market capsules used in treating overactive...
    Zydus gets USFDA nod to market anti-diuretic nasal spray

    Zydus gets USFDA nod to market anti-diuretic nasal spray

    Ruby Khatun Khatun5 Oct 2017 10:17 AM IST
    New Delhi: Drug firm Zydus Cadila said it has received final approval from the US health regulator to market anti-diuretic Desmopressin nasal spray...
    Next

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok